Influence of low-dose acetylsalicylacid on the treatment result of patients with pneumonia (benefit of ASS with CAP) - a retrospective data analysis

• Conditions: J18; R65; A41; R57.2; Pneumonia, organism unspecified; Systemic Inflammatory Response Syndrome [SIRS]; Other sepsis; Septic shock

• Registration Number: DRKS00007626
• Lead Sponsor: niversitätsklinikum Jena

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2013-12-10
• Study Start: 2015-02-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 365

Inclusion Criteria

Pneumonia

Exclusion Criteria

1. hospital stay <4 days; 2. transfer from another hospital; 3. pregnancy; 4. diagnosis of lung cancer; 5. diagnosis of tuberculosis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. mortality during hospital stay; 2. Organ failure (incl. considering pre-existing organ dysfunctions) in the time period concerned; 3. occurence of SIRS or sepsis or septic shock

Secondary Outcome Measures

Name	Time	Method
1. duration (days) of hospital and ICU stay considering geriatric treatments; 2. occurence of haemostaseologic and bleeding complications; 3. maximum for APACHE II and SOFA score of ICU patients